Case Study

It is 2033, and antibiotic resistance is no longer a threat. How did we get there? (Mini Case)

4 pages
October 2024
Reference: IMD-7-2614

In the early 2000s, addressing antibiotics resistance seemed like an insurmountable threat. The World Health Organization (WHO) projected that it would claim 8–10 million lives annually by 2050 if left unchecked. Antibiotics, long considered a miracle of modern medicine, had, over time, become increasingly ineffective as bacteria evolved mechanisms to resist them. What was once a triumph of science had slowly turned into a global nightmare, and finding the solution to this potential crisis had been as much about fixing economic systems as it was about developing new drugs. The good news is that by 2033, the world has turned the corner and addressed an enormous global health problem. How did we solve it “before we had to?”

Learning Objective
  • Apply the future-back approach to a real-life global health issue
Keywords
Sustainability, Future Shaping, System Change, Market Failure, Good Health, Well-being
Settings
World/global
Healthcare
2024-2033
Type
Published Sources
Copyright
© 2024
Available Languages
English
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Center for Sustainable & Inclusive Business
Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics